PRESS RELEASE Eli Lilly Italy: a new €750 million pact with Italy by 2025
Lilly's manufacturing site in the Sesto Fiorentino area is one of the largest and most innovative biotechnology drug manufacturing facilities in Italy and one of the largest within Eli Lilly's global manufacturing network.
Tags in this Article:
No categories
Related articles
Lilly plans to invest €400 million in new biopharmaceutical manufacturing facility in...
Lilly has announced plans to invest over €400 million in a brand-new manufacturing facility in Limerick, Ireland, subject to planning approval. This marks Lilly’s fifth manufacturing plant in Europe.
Lilly’s policy position on obesity in Europe
Obesity is a health challenge that has reached epidemic proportions, and it continues to escalate. The EU can play an instrumental role in driving the improvement of obesity care in Member States, with the goal of improving health outcomes and avoiding costly complications. There is a need for immediate action, or else the scale of obesity and its consequences will soon become an unbearable burden on our health systems.
A Day of Giving: Global Day of Service
This year marks the 15th anniversary of our Global Day of Service (GDOS), where Lilly employees worldwide volunteer in their local communities. Since the inaugural GDOS in 2008, our team has made an impact in 65 countries, racking up more than 1.2 million service hours and completing more than 1,000 community service projects.